Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 164

The DOI matches its Crossref record.

Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions.

Armitage, J O, Weisenburger, D D, Hutchins, M, Moravec, D F, Dowling, M, Sorensen, S, Mailliard, J, Okerbloom, J, Johnson, P S, Howe, D·1986·Journal of Clinical Oncology

Abstract

Fifty-one patients with diffuse large-cell lymphoma (DLCL) were treated with a six-drug combination chemotherapy regimen including cyclophosphamide, doxorubicin, procarbazine, bleomycin, vincristine, and prednisone. The patients were restaged after three cycles of therapy, and restaging was repeated at 2-month intervals in patients who had persistent disease. Responding patients received two cycles of therapy after documentation of complete remission (CR). With all patients considered evaluable, 73% of the patients achieved a CR. Twenty-six of the 37 CRs (70%) achieved remission in the first three treatment cycles. The durability of remission in the rapidly responding patients was significantly better than for patients who required five cycles to achieve CR (80% v 40% at 2 years, P = .02) despite the latter patients having received two more cycles of therapy. Rapidly responding patients with DLCL do not require prolonged therapy and have a better prognosis than patients achieving a CR more slowly.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.1986.4.2.160

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 164

Metadata

Authors
Armitage, J. O., Weisenburger, D. D., Hutchins, M., Moravec, D. F., Dowling, M., Sorensen, S., Mailliard, J., Okerbloom, J., Johnson, P. S., & Howe, D.
Venue
Journal of Clinical Oncology
Published
1986-02
Volume
4
Issue
2
Pages
160-164
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2225668169
Cited by
164
References
0
FWCI
5.29
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions. https://app.cochat.ai/papers/10.1200/jco.1986.4.2.160
The paper
Armitage, J. O., Weisenburger, D. D., Hutchins, M., Moravec, D. F., Dowling, M., Sorensen, S., Mailliard, J., Okerbloom, J., Johnson, P. S., & Howe, D. (1986). Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions. Journal of Clinical Oncology. https://doi.org/10.1200/jco.1986.4.2.160

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.